Navis Capital Partners will complete its exit from WorldMark Group after agreeing to sell the Australia-based after-market car services provider to Quadrant Private Equity. Following the earlier sale of WorldMark’s consulting business, total proceeds...
Quadrant Private Equity has acquired a majority stake in Injury Treatment, an Australia-based provider of injury prevention and rehabilitation services to employers and insurers, for an undisclosed sum.
Quadrant Private Equity, which recently closed its eighth Australia mid-market fund at $980 million ($754 million), has agreed to buy Ardent Leisure’s Goodlife Health Clubs business for A$260 million.
Mark Sowerby, founder and managing director of Australia-based Blue Sky Alternative Investments, will retire from the firm.
Bridgeport Capital has taken full ownership of Hawkesbridge Private Equity and will integrate the latter’s portfolio into its own. This follows a management buyout of Hawkesbridge’s property unit at the end of last year.
Blackbird Ventures’ Rick Baker sees his unplanned career path as essential to helping build the strengths needed to help revive Australia’s venture capital scene
Australian GP Quadrant Private Equity has closed its eighth fund - and fifth as a fully independent entity - at A$980 million ($754 million). As with the previous fundraise in early 2014, the process was completed in approximately one month.
A US-based healthcare fund backed by Microsoft founder Bill Gates has led a A$4.5 million ($3.5 million) investment round in Australian medical technology company Atomo Diagnostics.
Australian VC firm Square Peg Capital has contributed to a $17 million Series B round for UpGuard, a Sydney-founded cybersecurity start-up now headquartered in the US.
Australia-listed investment firm CVC has backed a A$3 million ($2.3 million) seed round of funding for Bigstone, a domestic online platform operator that connects investors with start-ups.
Leveraging its synergies with Westpac, Reinventure Group will invest in start-ups through which the bank can access innovations that complement its business model or integrate technology solutions directly into its systems
Caisse de dépôt et placement du Québec (CDPQ) has agreed to acquire a 20% stake in Plenary Group Holdings, which controls the Australian operations of the global specialist infrastructure investor Plenary Group.
Australia’s Future Fund has led a $50 million round of funding for US-based big data services company MapR Technologies.
Equity Venture Partners (EVP) and Microequities Asset Management have launched a A$20 million ($15.4 million) venture capital fund to focus on Australian technology start-ups.
The exponential rise in drone technology investment during the past few years is now expected to level off into slower growth as venture capitalists discover a galaxy of more nuanced opportunities
US private equity firm SCF Partners and Australia's Viburnum Funds have agreed to acquire the Asia Pacific subsea services business of Netherlands-based Fugro.
Australia's Westpac Banking Corp. has committed A$50 million ($38 million) to the second fund of Reinventure Group.
State-controlled Telkom Indonesia has partnered with Australia’s Telstra Ventures to pursue venture capital investment opportunities in Southeast Asia.
RGT Capital, a multi-family office investment vehicle based in Australia, has acquired a stake in Australian investment company AxiCorp.
The Australian government has seeded $250 million ($191 million) from its Medical Research Future Fund (MRFF) to a biomedical technology-focused venture investment vehicle. It will match private sector commitments, bringing the total available for deployment...
Allegro invested in capacity and boosted international sales in order to turn Vulcanite from a corporate orphan into an independent player with strong growth prospects. The sale of the business to Continental generated a 2x return
L Capital Asia – a private equity arm of French luxury goods giant LVMH – has appointed Louis Vuitton Australia CEO Philip Corne as its executive chairman in Australia.
Primavera Capital and Shanghai Pharmaceuticals have agreed to buy Australia-listed nutrition and healthcare products company Vitaco for approximately A$313 million ($238 million).
New Zealand-based start-up incubator and investor Powerhouse Ventures has filed to raise as much as A$20 million ($15.2 million) through an Australian IPO.